London: Britain has approved the conditional use of the world’s first antiviral pill, believed to be helpful in the successful treatment of Kovid-19. The UK is the first country to recognize treatment with this pill as suitable, although it is not clear how soon the pill will be available. Corona-infected people of 18 years of age and above have been approved to use this pill in whom at least one factor is seen that can make the condition serious. The name of this drug is Molnupiravir (Molnupiravir).
According to reports, individuals with mild infection of Kovid will have to take this pill twice a day. This antiviral pill reduces the symptoms of corona and helps in faster recovery. This can be helpful in reducing the burden on hospitals and curbing infections in poor countries. This pill will be helpful in the two methods necessary to fight against the epidemic, medicine and prevention. Relevant regulators in the US, Europe and some other countries are reviewing the drug.
The US Food and Drug Administration said last month that it would convene a panel meeting in late November to determine the safety and effectiveness of the pill. The drug manufacturer ‘Merck’ has developed this drug. In October British officials announced they had achieved 480,000 doses of Molnupiravir and were expected to help treat thousands more this winter. UK Health Minister Sajid Javid said, ‘This is a historic day for our country as the UK is the first country in the world to approve an antivirus that can be taken at home to treat Kovid.’